Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

697 ARTÍCULOS , VIENDO DEL 496 AL 510

Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition

Hayek D, Ziegler G, Kleineidam L, Brosseron F, Nemali A, Vockert N, Ravichandran KA, Betts MJ, Peters O, Schneider LS, Wang X, Priller J, Altenstein S, Schneider A, Fliessbach K, Wiltfang J, Bartels C, Rostamzadeh A, Glanz W, Buerger K, Janowitz D, Perneczky R, Rauchmann BS, Teipel S, Kilimann I, Laske C, Mengel D, Synofzik M, Munk MH, Spottke A, Roy N, Roeske S, Kuhn E, Ramirez A, Dobisch L, Schmid M, Berger M, Wolfsgruber S, Yakupov R, Hetzer S, Dechent P, Ewers M, Scheffler K, Schott BH, Schreiber S, Orellana A, de Rojas I, Marquié M, Boada M, Sotolongo O, González PG, Puerta R, Düzel E, Jessen F, Wagner M, Ruiz A, Heneka MT, Maass A.

Mol Psychiatry. 2024 Apr;29(4):992-1004. doi: 10.1038/s41380-023-02387-3. Epub 2024 Jan 12.

Degeneration of the cholinergic system in individuals with subjective cognitive decline: A systematic review

Rodriguez-Hernandez MA, Alemany I, Olofsson JK, Diaz-Galvan P, Nemy M, Westman E, Barroso J, Ferreira D, Cedres N.

Neurosci Biobehav Rev. 2024 Feb;157:105534. doi: 10.1016/j.neubiorev.2024.105534. Epub 2024 Jan 14.

Digital Clock Drawing as an Alzheimer's Disease Susceptibility Biomarker: Associations with Genetic Risk Score and APOE in Older Adults

Thompson LI, Cummings M, Emrani S, Libon DJ, Ang A, Karjadi C, Au R, Liu C.

J Prev Alzheimers Dis. 2024;11(1):79-87. doi: 10.14283/jpad.2023.48.

Blood Biomarkers of Alzheimer's Disease and Cognition: A Literature Review

Garcia-Escobar G, Manero RM, Fernández-Lebrero A, Ois A, Navalpotro-Gómez I, Puente-Periz V, Contador-Muñana J, Estragués-Gazquez I, Puig-Pijoan A, Jiménez-Balado J.

Biomolecules. 2024 Jan 11;14(1):93. doi: 10.3390/biom14010093.

Association of Plasma YKL-40 With MRI, CSF, and Cognitive Markers of Brain Health and Dementia

Pase MP, Himali JJ, Puerta R, Beiser AS, Gonzales MM, Satizabal CL, Yang Q, Aparicio HJ, Kojis DJ, Decarli CS, Lopez OL, Longstreth W, Gudnason V, Mosley TH, Bis JC, Fohner A, Psaty BM, Boada M, García-González P, Valero S, Marquié M, Tracy R, Launer LJ, Ruiz A, Fornage M, Seshadri S.

Neurology. 2024 Feb 27;102(4):e208075. doi: 10.1212/WNL.0000000000208075. Epub 2024 Jan 30.

Investigating White Matter Neuroinflammation in Alzheimer Disease Using Diffusion-Based Neuroinflammation Imaging

Wang Q, Schindler SE, Chen G, Mckay NS, McCullough A, Flores S, Liu J, Sun Z, Wang S, Wang W, Hassenstab J, Cruchaga C, Perrin RJ, Fagan AM, Morris JC, Wang Y, Benzinger TLS.

Neurology. 2024 Feb;102(4):e208013. doi: 10.1212/WNL.0000000000208013. Epub 2024 Feb 5.

Association between plasma CTRPs with cognitive impairment and neurodegeneration of Alzheimer's disease

Huang X, Zhao J, Wang Q, Yan T, Gou S, Zhu X, Yang L, Ye F, Zhang J, Wang Y, Yang S, Le W, Xiang Y.

CNS Neurosci Ther. 2024 Feb;30(2):e14606. doi: 10.1111/cns.14606.

New horizons in the diagnosis and management of Alzheimer's Disease in older adults

Dolphin H, Dyer AH, Morrison L, Shenkin SD, Welsh T, Kennelly SP.

Age Ageing. 2024 Feb 1;53(2):afae005. doi: 10.1093/ageing/afae005.

Present and Future of Blood-Based Biomarkers of Alzheimer's Disease: Beyond the Classics

Mantellatto Grigoli M, Pelegrini LNC, Whelan R, Cominetti MR.

Brain Res. 2024 May 1;1830:148812. doi: 10.1016/j.brainres.2024.148812. Epub 2024 Feb 17.

Biomarker Changes during 20 Years Preceding Alzheimer's Disease

Jia J, Ning Y, Chen M, Wang S, Yang H, Li F, Ding J, Li Y, Zhao B, Lyu J, Yang S, Yan X, Wang Y, Qin W, Wang Q, Li Y, Zhang J, Liang F, Liao Z, Wang S.

N Engl J Med. 2024 Feb 22;390(8):712-722. doi: 10.1056/NEJMoa2310168.

The free plasma amyloid Aβ(1)(-)(42)/Aβ(1)(-)(40) ratio predicts conversion to dementia for subjects with mild cognitive impairment with performance equivalent to that of the total plasma Aβ(1)(-)(42)/Aβ(1)(-)(40) ratio. The BALTAZAR study

Schraen-Maschke S, Duhamel A, Vidal JS, Ramdane N, Vaudran L, Dussart C, Buée L, Sablonnière B, Delaby C, Allinquant B, Gabelle A, Bombois S, Lehmann S, Hanon O; BALTAZAR study group.

Neurobiol Dis. 2024 Apr;193:106459. doi: 10.1016/j.nbd.2024.106459. Epub 2024 Feb 27.

The association of glucose metabolism measures and diabetes status with Alzheimer's disease biomarkers of amyloid and tau: A systematic review and meta-analysis

van Gils V, Rizzo M, Côté J, Viechtbauer W, Fanelli G, Salas-Salvadó J, Wimberley T, Bulló M, Fernandez-Aranda F, Dalsgaard S, Visser PJ, Jansen WJ, Vos SJB.

Neurosci Biobehav Rev. 2024 Apr;159:105604. doi: 10.1016/j.neubiorev.2024.105604. Epub 2024 Feb 27.

Imaging Biomarkers of VCI: A Focused Update

Clancy U, Kancheva AK, Valdés Hernández MDC, Jochems ACC, Muñoz Maniega S, Quinn TJ, Wardlaw JM.

Stroke. 2024 Apr;55(4):791-800. doi: 10.1161/STROKEAHA.123.044171. Epub 2024 Mar 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias